A Feasibility Study of an AI-Powered Clinical Decision Aid for Personalized Depression Treatment Selection

NACompletedINTERVENTIONAL
Enrollment

17

Participants

Timeline

Start Date

December 16, 2019

Primary Completion Date

December 31, 2020

Study Completion Date

December 31, 2020

Conditions
Depression
Interventions
DEVICE

Clinical Decision Aid

The Clinical Decision Aid is a predictive model that takes as input individual patient characteristics, called 'features', which are inputted by the physician or by patient self-report, and outputs a list of all possible treatments, with each treatment associated with a predicted efficacy (likelihood to achieve response and likelihood to achieve remission, each expressed as a percentage). The treatments, which may include any approved treatment for depression, will be ordered by efficacy and presented to the physician. Lifestyle interventions, such as exercise or mindfulness, which have an evidence base, but do not require formal regulatory approval, will also be outputted. The system will additionally produce a side effect profile for each pharmacological treatment recommended, including known side effects, modified by a prediction about which side effects may be more likely for a given individual based on their individual characteristics.

Trial Locations (1)

H4H 1R3

Douglas Mental Health University Institute, Verdun

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Aifred Health Inc.

INDUSTRY